ABL Diagnostics Société anonyme (EPA:ABLD)
France
· Delayed Price · Currency is EUR 5.10
+0.44 (9.44%)
Feb 20, 2025, 9:00 AM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €85.40 million as of February 21, 2025. Its market cap has decreased by -45.36% in one year.
Market Cap
85.40M
Enterprise Value
86.80M
Revenue
6.21M
Ranking
n/a
PE Ratio
462.50
Stock Price
€5.10
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 85.40M, an increase of 3,305.12%. That is a compound annual growth rate of 15.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 85.40M | 115.45% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 134.23B |
| Sanofi | 129.22B |
| Sartorius Stedim Biotech | 19.83B |
| bioMérieux | 13.46B |
| Eurofins Scientific SE | 9.06B |
| Ipsen | 9.05B |
| Virbac | 2.55B |
| emeis Société anonyme | 1.40B |